Insider Transactions in Q4 2025 at Savara Inc (SVRA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
David A Ramsay |
SELL
Open market or private sale
|
Direct |
20,000
-0.78%
|
$120,000
$6.06 P/Share
|
|
Dec 16
2025
|
David L Lowrance Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
32,000
-10.06%
|
-
|
|
Dec 16
2025
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
128,995
-9.79%
|
-
|
|
Dec 14
2025
|
David L Lowrance Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
62,960
-16.52%
|
$377,760
$6.92 P/Share
|
|
Dec 14
2025
|
Robert Matthew Lutz Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
67,760
-18.73%
|
$406,560
$6.92 P/Share
|
|
Dec 14
2025
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
195,705
-12.94%
|
$1,174,230
$6.92 P/Share
|
|
Dec 14
2025
|
Anne Erickson Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
62,960
-14.48%
|
$377,760
$6.92 P/Share
|
|
Dec 14
2025
|
Kathleen R. Mc Cabe Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,350
-7.04%
|
$236,100
$6.92 P/Share
|
|
Dec 10
2025
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
23,629
-1.54%
|
-
|
|
Dec 09
2025
|
Richard J Hawkins |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+19.87%
|
-
|
|
Dec 09
2025
|
Joseph S Mc Cracken |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+11.74%
|
-
|
|
Dec 09
2025
|
David A Ramsay |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+1.54%
|
-
|
|
Dec 09
2025
|
Nevan C Elam |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.23%
|
-
|
|
Dec 09
2025
|
An Van Es Johansson |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+28.07%
|
-
|
|
Dec 04
2025
|
Yasmine Wasfi Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,992
-11.57%
|
$131,952
$6.37 P/Share
|
|
Dec 02
2025
|
Nevan C Elam |
SELL
Payment of exercise price or tax liability
|
Direct |
1,473
-2.15%
|
$7,365
$5.81 P/Share
|
|
Dec 02
2025
|
Nevan C Elam |
BUY
Exercise of conversion of derivative security
|
Direct |
5,860
+7.9%
|
$5,860
$1.46 P/Share
|
|
Nov 14
2025
|
Richard J Hawkins |
BUY
Exercise of conversion of derivative security
|
Direct |
5,860
+4.61%
|
$5,860
$1.46 P/Share
|
|
Oct 20
2025
|
Yasmine Wasfi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+15.56%
|
-
|